Management of Transaminitis with Portal Vein at Upper Limit of Normal

Diagnostic Approach

The American Association for the Study of Liver Diseases recommends obtaining Doppler ultrasound immediately as first-line investigation to confirm or exclude portal vein thrombosis, looking specifically for absent lumen flow, echogenic material within the vessel, and collateral vessel formation 1, 2
If ultrasound is equivocal with portal vein at upper limit of normal, proceed directly to contrast-enhanced CT or MRI for definitive assessment of thrombus presence and extension 1, 2
Look for associated findings suggesting early thrombosis: bowel wall thickening, mesenteric fat stranding, splenomegaly, or ascites 3

The American College of Gastroenterology recommends initiating anticoagulation immediately without delay, as treatment within 2 weeks achieves 87% recanalization versus 44% when delayed beyond 2 weeks 6, 7
For patients without cirrhosis: Start low-molecular-weight heparin immediately, transition to warfarin for minimum 6 months 8, 4
For compensated cirrhosis: Direct oral anticoagulants preferred, offering superior recanalization without increased bleeding risk 9, 6, 7

Obtain cross-sectional imaging every 3 months to assess recanalization; portal vein recanalization expected within 6 months, mesenteric veins up to 12 months 6, 8, 4
Perform endoscopic variceal screening as soon as feasible, as 55% of patients failing recanalization develop varices 6, 8, 5

Child-Pugh class A/B: DOACs preferred for convenience and superior outcomes 9, 6
Child-Pugh class C: LMWH only; avoid DOACs due to unpredictable metabolism and bleeding risk 9, 6
Lifelong anticoagulation indicated for myeloproliferative neoplasms, antiphospholipid syndrome, or inherited thrombophilia with PVT 1, 2, 7